Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Connie Wehmeyer"'
Publikováno v:
Molecular Genetics and Metabolism. 129:S161
Autor:
Carlos E. Prada, Lisa Berry, Robert E. Wood, Connie Wehmeyer, Robert J. Hopkin, Madeleine Bordley, Laurie Bailey, Anatalia Labilloy
Publikováno v:
Molecular Genetics and Metabolism. 129:S32
Publikováno v:
Molecular Genetics and Metabolism. 126:S89
Mucopolysaccharidosis type II (MPS II) is an X-linked lysosomal disorder caused by deficiency of iduronate 2-sulfatase resulting in progressive accumulation of dermatan and heparan sulfate with multisystem involvement including neurological, respirat
Publikováno v:
Molecular Genetics and Metabolism. 120:S24
Publikováno v:
Molecular Genetics and Metabolism. 117:S120
Publikováno v:
Molecular Genetics and Metabolism. 117:S28
Publikováno v:
Molecular Genetics and Metabolism. 114:S22
Publikováno v:
Molecular Genetics and Metabolism. 114:S127
Autor:
Nancy D. Leslie, Carlos E. Prada, Lisa Berry, Laurie Bailey, Gregory A. Grabowski, Robert J. Hopkin, Connie Wehmeyer, Kim M. Cecil
Publikováno v:
Molecular Genetics and Metabolism. 105:S53-S54
Publikováno v:
Molecular Genetics and Metabolism. 108:S97
4-one) is an isoflavone which has been proposed as a potential drug for the use in substrate reduction therapy (SRT) in mucopolysaccharidoses and other lysosmal storage diseases (LSD). It was proposed that the effect of genistein to reduce the lysoso